CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2004-07-07): Appendectomy not linked to primary sclerosing cholangitis

Epidemiology

Appendectomy not linked to primary sclerosing cholangitis

Last Updated: 2004-07-07 14:50:18 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Contrary to what is seen with ulcerative colitis, appendectomy is not associated with the development of primary sclerosing cholangitis (PSC), according to a report published in the July issue of Gut. However, for both ulcerative colitis and PSC, appendectomy is tied to a delay in disease onset.

In agreement with previous research, the appendectomy rate for patients who developed ulcerative colitis was four times lower than that seen in matched controls (p = 0.0001). By contrast, a history of this surgical procedure did not seem to raise or lower the risk of PSC or affect disease severity in patients with concomitant inflammatory bowel disease (IBD).

To investigate the interaction between appendectomy and these diseases, Dr. T. H. J. Florin, from the University of Queensland in Brisbane, Australia, and colleagues analyzed data from 78 PSC-IBD patients, 12 pure PSC patients, 294 ulcerative colitis patients, and 1466 matched controls.

In all three patient groups, appendectomy was associated with a delay in disease onset of about 5 years, the researchers report. Moreover, this held true even after accounting for smoking status.

Prior appendectomy had no bearing on disease extent or severity in patients with PSC-IBD. In the ulcerative colitis group, by contrast, this surgery was linked to more extensive disease, but also with a reduced need for immunosuppression or colectomy (p = 0.004).

In the PSC-IBD and ulcerative colitis groups, appendectomy was tied to an increased risk of high-grade dysplasia or colorectal cancer, but the association fell short of statistical significance. However, in a meta-analysis combining data from the present and past studies, appendectomy raised the risk of colorectal cancer in ulcerative colitis patients by 15-fold (p = 0.004).

"Further prospective studies are required to characterize the influence of appendectomy on the extent of colitis in IBD and on the associated dysplasia or colorectal cancer," the investigators note.

Gut 2004;53:973-979.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.